The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

Cheniere has won approval from the Federal Energy Regulatory Commission (FERC) to build two new midscale liquefaction trains at its Corpus Christi liquefied natural gas export facility in Texas ...

Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months.

Reproxalap, a first-in-class small-molecule modulator of reactive aldehyde species (RASP), is under review for the treatment of the signs and symptoms of dry eye disease. It works by covalently ...

BBVA SA plans to offer retail clients in Spain access to cryptocurrencies, after receiving regulatory approval from market supervisor CNMV to provide custody and execution services for such assets.

This outlook was written by Bloomberg’s Regulatory Affairs team. While there is a new focus on ‘Deregulation’ and ’Simplification’ for regulators globally, the regulatory landscape is ...

Banco Bilbao Vizcaya Argentaria (BBVA) announced on March 10 that it had received the nod from Spain’s securities regulator, the Comisión Nacional del Mercado de Valores (CNMV), to offer ...

While Ohio seeks to implement work requirements for the Medicaid expansion group, those members could be at risk of losing coverage all together as state and federal lawmakers look to Medicaid to ...

What regulations, legal frameworks, and policies will your network need to comply with? You next need to understand what regulatory frameworks your network may or may not need to comply with–both for ...

The FDA is expected to decide on treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine. Reproxalap, a first-in-class small-molecule ...

Tris Pharma has announced positive data from two Phase III trials of cebranopadol, as well as positive data from a human abuse potential (HAP) study to compare the therapy against various opioids.